Research & Development (Pharma & Healthcare)

Pharma & Healthcare R&D Reports

Research & Development (Pharma & Healthcare) Market Research Reports, Industry Analysis and Trends

 

Publication Single User License (PDF) Price
Global Bioinformatics Market 2015-2019

Global Bioinformatics Market 2015-2019

Date Published: May 20 2015
Report forecast the global bioinformatics market to grow at a CAGR of 19.49% over the period 2014-2019.
 
$2,500.00
Serotonin (5-HT) Receptor Agonists -Pipeline Insights, 2015

Serotonin (5-HT) Receptor Agonists -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Serotonin (5-HT) Receptor Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Serotonin (5-HT) Receptor Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Serotonin (5-HT) Receptor Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Idiopathic Thrombocytopenic Purpura (Immune Thombocytopenic Purpura)-Pipeline Insights, 2015

Idiopathic Thrombocytopenic Purpura (Immune Thombocytopenic Purpura)-Pipeline Insights, 2015

Date Published: May 14 2015

Summary

$1,250.00
Akt3 Inhibitors -Pipeline Insights, 2015

Akt3 Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Akt3 Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Akt3 Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Akt3 Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Monoamine Oxidase A (MAO-A) Inhibitors -Pipeline Insights, 2015

Monoamine Oxidase A (MAO-A) Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Monoamine Oxidase A (MAO-A) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Monoamine Oxidase A (MAO-A) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Monoamine Oxidase A (MAO-A) Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Dementia Associated With Alzheimer's Disease-Pipeline Insights, 2015

Dementia Associated With Alzheimer's Disease-Pipeline Insights, 2015

Date Published: May 14 2015

Summary

$1,250.00
 Rhabdomyosarcoma-Pipeline Insights, 2015

Rhabdomyosarcoma-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Rhabdomyosarcoma- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Rhabdomyosarcoma. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Rhabdomyosarcoma Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Fyn Tyrosine Kinase Inhibitors -Pipeline Insights, 2015

Fyn Tyrosine Kinase Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Fyn Tyrosine Kinase Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Fyn Tyrosine Kinase Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Fyn Tyrosine Kinase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Acute Bacterial Sinusitis-Pipeline Insights, 2015

Acute Bacterial Sinusitis-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Acute Bacterial Sinusitis- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Acute Bacterial Sinusitis. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Acute Bacterial Sinusitis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Muscle Wasting Disorders-Pipeline Insights, 2015

Muscle Wasting Disorders-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Muscle Wasting Disorders- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Muscle Wasting Disorders. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Muscle Wasting Disorders Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Beta-2 Receptors  Antagonists -Pipeline Insights, 2015

Beta-2 Receptors Antagonists -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Beta-2 Receptors Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Beta-2 Receptors Antagonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Beta-2 Receptors Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Pim Kinase 1 (PIM-1) Inhibitors -Pipeline Insights, 2015

Pim Kinase 1 (PIM-1) Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Pim Kinase 1 (PIM-1) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Pim Kinase 1 (PIM-1) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Pim Kinase 1 (PIM-1) Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Graft Versus Host Disease (GVHD)-Pipeline Insights, 2015

Graft Versus Host Disease (GVHD)-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Graft Versus Host Disease (GVHD)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Graft Versus Host Disease (GVHD). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Graft Versus Host Disease (GVHD) Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Vascular Dysfunction-Pipeline Insights, 2015

Vascular Dysfunction-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Vascular Dysfunction- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Vascular Dysfunction. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Vascular Dysfunction Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Interleukin-11 (IL-11) Receptor Agonists -Pipeline Insights, 2015

Interleukin-11 (IL-11) Receptor Agonists -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Interleukin-11 (IL-11) Receptor Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Interleukin-11 (IL-11) Receptor Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Interleukin-11 (IL-11) Receptor Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Cardiovascular Inflammation-Pipeline Insights, 2015

Cardiovascular Inflammation-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Cardiovascular Inflammation- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Cardiovascular Inflammation. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Cardiovascular Inflammation Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Pompe Disease-Pipeline Insights, 2015

Pompe Disease-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Pompe Disease- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Pompe Disease. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Pompe Disease Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Dihydropteroate Synthetase (DHPS) Inhibitors -Pipeline Insights, 2015

Dihydropteroate Synthetase (DHPS) Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Dihydropteroate Synthetase (DHPS) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Dihydropteroate Synthetase (DHPS) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Dihydropteroate Synthetase (DHPS) Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Telomerase Activators -Pipeline Insights, 2015

Telomerase Activators -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Telomerase Activators- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Telomerase Activators. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Telomerase Activators Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Left Ventricular Dysfunction-Pipeline Insights, 2015

Left Ventricular Dysfunction-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Left Ventricular Dysfunction- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Left Ventricular Dysfunction. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Left Ventricular Dysfunction Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data